Rollins News Center
Experts Offer Vital Insights on Mifepristone Safety, Efficacy, and Access
On March 26, the U.S. Supreme Court will hear oral arguments in a case that could limit access to mifepristone, a drug primarily used in medication abortion. Researchers from the Center for Reproductive Health Research in the Southeast weigh in on the state of mifepristone access, the potential implications of this case, and what the public needs to know.
Read More